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Abstract
Background: Bifidobacterium longum is a common member of the human gut microbiota and is frequently present
at high numbers in the gut microbiota of humans throughout life, thus indicative of a close symbiotic host-microbe
relationship. Different mechanisms may be responsible for the high competitiveness of this taxon in its human host
to allow stable establishment in the complex and dynamic intestinal microbiota environment. The objective of this
study was to assess the genetic and metabolic diversity in a set of 20 B. longum strains, most of which had
previously been isolated from infants, by performing whole genome sequencing and comparative analysis,
and to analyse their carbohydrate utilization abilities using a gene-trait matching approach.
Results: We analysed their pan-genome and their phylogenetic relatedness. All strains clustered in the B.
longum ssp. longum phylogenetic subgroup, except for one individual strain which was found to cluster in
the B. longum ssp. suis phylogenetic group. The examined strains exhibit genomic diversity, while they also
varied in their sugar utilization profiles. This allowed us to perform a gene-trait matching exercise enabling
the identification of five gene clusters involved in the utilization of xylo-oligosaccharides, arabinan, arabinoxylan, galactan
and fucosyllactose, the latter of which is an abundant human milk oligosaccharide (HMO).
Conclusions: The results showed high diversity in terms of genes and predicted glycosyl-hydrolases, as well as the ability
to metabolize a large range of sugars. Moreover, we corroborate the capability of B. longum ssp. longum to metabolise
HMOs. Ultimately, their intraspecific genomic diversity and the ability to consume a wide assortment of carbohydrates,
ranging from plant-derived carbohydrates to HMOs, may provide an explanation for the competitive advantage and
persistence of B. longum in the human gut microbiome.
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Background
The human gut microbiota harbours a complex and
dynamic microbial community, which plays various
functional roles to support human physiology and health
[1]. This so-called “hidden organ” elicits important
metabolic, structural and protective activities, and influ-
ences behaviour and brain function through the
proposed “gut-brain-axis” [2, 3]. Bifidobacteria are among
the first colonisers of the gut and represent common
intestinal inhabitants throughout life, being purported as
beneficial for the host [4–6]. Certain Bifidobacterium
species are more frequently detected as gut commensals
during early life and childhood, when the microbiota
undergoes a succession to an adult-like composition after
weaning [5, 7]. Bifidobacteria are Gram-positive, high G +
C content, rod shaped, non-motile and non-spore-forming
bacteria, belonging to the Actinobacteria phylum [8]; cur-
rently the genus Bifidobacterium includes 51 species and
10 subspecies, of which eight have been only recently
identified (http://www.bacterio.net/bifidobacterium.html).
Functional genome analysis has been vital to unravel the
genetic strategies adopted by bifidobacteria to colonize the
intestinal tract, a feature that appears to be facilitated by
their adaptation to a glycan-rich environment [9]. More
than 13% of the so-called clusters of orthologous gene
(COG) families in the Bifidobacterium pan-genome are as-
sociated with carbohydrate metabolism [9]. Consequently,
this saccharolytic genotype allows bifidobacteria to
metabolize a variety of carbohydrates (host- and diet-der-
ived substrates), which are not digested by the host’s digest-
ive enzymes [10], to provide a competitive advantage in the
complex gut environment.
Among the bifidobacteria colonizing the human gut,
Bifidobacterium longum deserves a special mention due
to its prevalence (and sometimes abundance) in both in-
fants and adults [11, 12]. Despite the shift in microbiota
composition following the transition from an exclusively
milk-based diet to solid foods, it has been demonstrated
that specific B. longum strains may persist in the intes-
tinal microbiota over time [13, 14]; in addition, strains
can be newly acquired by the adult host [15], being asso-
ciated with health benefits for the host [16]. The B.
longum taxon currently recognizes four subspecies:
longum, infantis, suis and suillum [17, 18]. Isolates of
the latter two subspecies are of animal origin [17, 19],
while the former two are considered to be characteristic
of the human gut microbiota. Genomic and functional
studies have indicated that B. longum ssp. infantis is
more specialized in the metabolism of milk glycans and
for this reason is more adapted to the gut of a breast-
feeding infant [20], being involved in the metabolism of
HMOs [21]. In spite of the close genetic relatedness, B.
longum ssp. longum strains are distinctly different from
their B. longum ssp. infantis relatives when assessing
carbohydrate utilization, with the former possessing vari-
ous enzymes that are active on plant-derived oligosac-
charides (while not encoding the same versatile
enzymatic ability to degrade HMOs) [22, 23]. These
metabolic capabilities exemplify the specific strategies
followed by these two subspecies for the adaptation to a
particular niche.
The correct assembly of the intestinal microbiota plays
a key role in health and well-being of the host. The mech-
anisms of bifidobacterial establishment and persistence in
the gut microbiota are far from being fully understood.
However, in the particular case of B. longum, their
diversity and capabilities to metabolize a large range of
carbohydrates, considered to be the result of gene duplica-
tion and horizontal gene transfer [9], seem to make them
particularly powerful microbial competitors in the
complex human gut environment [24]. For these reasons,
investigating metabolic abilities related to sugar fermenta-
tion and corresponding genetic functions is important to
fully understand and appreciate how and which microbes
can persist in the gut. In this context, the objective of this
study was to explore the intraspecific genomic diversity
within a pool of B. longum strains by performing whole
genome sequencing and comparative analysis, and to
analyse their carbohydrate utilization abilities using a
gene-trait matching (GTM) approach.
Results
General genome features
In order to determine the genetic content, diversity and
general characteristics of B. longum, especially strains
previously isolated from babies (Table 1), we performed
genome sequencing of 20 selected isolates in order to
perform a comparative analysis against a number of pub-
licly available B. longum genomes (for salient properties
of these genomes see Additional file 1: Table S1). The
sequencing and assembly efforts resulted in a set of unor-
iented contigs ranging in number from 20 to 72 per strain.
In order to facilitate a coherent comparative analysis, we
carried out a uniform open reading frame (ORF) predic-
tion for all our 20 sequenced genomes in addition to the
fully-sequenced B. longum genomes retrieved from public
databases (https://www.ncbi.nlm.nih.gov/genome/genom
es/183). As outlined in Table 1, the number of predicted
ORFs ranged from 2189 for B. longum APC1503 to 1761
for B. longum APC1477, with an average value of 1961 ±
107 identified ORFs per genome. The average percentage
G +C content was calculated to be 59.99 ± 0.20%, and
ranged from 59.6% for B. longum APC1465 to 60.4% for
B. longum DPC6316. The genome sizes follow a normal
distribution with an average value of 2.39 Mbp, where B.
longum APC1503 has the largest genome (2.56 Mbp) and
B. longum APC1478 the smallest (2.22 Mbp), which is
presumed to be equal or at least very close to the actual
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genome size as Illumina-based genome sequencing does
not allow complete closure of the bacterial chromosome
[25].
Comparative analyses
Employing a BLASTP-mediated comparative genomic
approach coupled with hierarchical clustering analysis
using the MCL algorithm (see Materials and Methods),
allowed us to define a pool of 1200 gene families that are
common among the 20 B. longum APC/DPC genomes
and fully sequenced genomes of B. longum (Additional
file 1: Table S1; Fig. 1a, b), thereby representing the pre-
dicted core genome. Core genes are present at least once
in every examined genome, and in this case account for
~33% of the total gene families obtained in our analysis
(Fig. 1c). The remaining 67% (which in total constitute
2433 gene families) represent genes that make up the
variable or dispensable genome, which consists of genes
that are present in some but not all genomes (Fig. 1b, c).
In line with what had been established previously [23]
regarding accessory gene functions (variable genome), we
observed gene families involved in the process of
colonization of, and adaptation to the host environ-
ment (e.g. surface proteins, sortase-dependent pili,
exopolysaccharide production, R/M systems), as well
as hypothetical proteins and mobile genetic elements.
Despite the fact that fragmented genome assemblies do
not allow a precise estimate of the occurrence, number
and chromosomal position of mobile DNA elements in
genomes, a search for genes encoding plasmid replication
functions (PF01051 and PF01446) revealed that at least 10
of the 20 sequenced genomes appear to contain plasmid(s)
(Table 1).
Furthermore, this analysis also revealed the presence of
608 unique or strain-specific genes (i.e. genes that are
present in just one of the analysed genomes), of which 227
are present in the B. longum APC/DPC genomes. These
genes represent the presumed truly unique genes (TUGs)
of each B. longum strain, and range between 60 in B.
longum APC1461 to 0 in B. longum APC1466 and B.
longum APC 1477 (Fig. 1a). The large percentage of genes
observed within the dispensable genome is a reflection of
a high level of diversity among the B. longum APC/DPC
strains, and also with respect to publicly available ge-
nomes. Interestingly, strains isolated from the same baby
generally cluster together based on hierarchical clustering
analysis (Fig. 1b). For example, two pairs of B. longum
APC/DPC strains (APC1465/APC1466 from subject C
and APC1477/APC1478 from subject H) which had been
isolated from samples collected at different dates, grouped
Table 1 Bifidobacterium longum genomes sequenced and analysed in this study
Genomes Source of Isolation Contigs No.
of
ORFs
Genome
Size (bp)
GC
content
(%)
No. of
unique
genes
Plasmids
(Rep+)
Reference
Subject Age Delivery Feeding
B. longum APC 1461 A 27 w CS BM 37 1987 2,418,994 60.0 60 No [49]
B. longum APC 1462 B 1 w NB BM 27 1992 2,417,784 60.2 4 Yes [49]
B. longum APC 1464 B 1 w NB BM 31 1918 2,346,522 60.0 3 Yes [49]
B. longum APC 1465 C 4 w NB BM 57 2032 2,452,211 59.6 6 Yes [49]
B. longum APC 1466 C 27 w NB BM 51 2026 2,419,982 59.8 0 Yes [49]
B. longum APC 1468 C 27 w NB BM 45 1994 2,395,158 60.1 12 Yes [49]
B. longum APC 1472 E 1 w CS BM 50 1927 2,364,041 60.1 3 Yes [49]
B. longum APC 1473 F 27 w CS BM 39 1874 2,317,071 59.8 6 No [49]
B. longum APC 1476 G 27 w NB BM 48 2151 2,532,540 60.0 1 Yes [49]
B. longum APC 1477 H 1 w NB BM 24 1761 2,228,807 59.8 0 No [49]
B. longum APC 1478 H 4 w NB BM 21 1766 2,223,352 59.8 1 No [49]
B. longum APC 1480 J 4 w NB BM 27 2084 2,477,750 59.9 6 No [49]
B. longum APC 1482 D 1 w NB FM 72 1899 2,337,438 60.1 17 No [49]
B. longum APC 1503 D 1 w NB FM 39 2189 2,562,703 59.7 23 No [49]
B. longum APC 1504 I 1 w NB BM 51 1883 2,310,288 60.2 14 No [49]
B. longum DPC 6316 K 25 y ND ND 32 1992 2,393,969 60.4 23 Yes [50]
B. longum DPC 6317 L 3 d ND ND 20 1987 2,448,630 60.2 8 No [50]
B. longum DPC 6320 M 64 y ND ND 25 1852 2,330,371 59.9 9 No [50]
B. longum DPC 6321 N 3 d ND ND 28 1941 2,382,360 59.9 24 Yes [50]
B. longum DPC 6323 O 4 d ND ND 52 1970 2,396,960 60.2 7 Yes [50]
w weeks, y years, d days, CS C-Section, NB natural birth, BM breast-milk, FM formula milk, ND not determined or unknown
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together based on their gene content. In contrast, B.
longum strains APC1462/APC1464, isolated from the
same baby from samples collected in the same week ex-
hibit clear genomic differences (Fig. 1b). Based on genome
alignment, presence of SNPs and gene content it is likely
that strain pair APC1477/APC1478, both isolated from
the same subject H within a relatively short time
frame (1 and 4 weeks), represent clonal derivatives of
the same strain (we detected just 2 different genes, 24
SNPs and an average nucleotide identity of 99.9%)
(Additional files 2, 3 and 4). Strains APC1465/APC1466
were isolated from subject C at an age of 4 and 27 weeks,
respectively, and despite being closely related, they do con-
tain a considerable number of genomic differences (we
detected 78 different genes and an average nucleotide iden-
tity of 99.7%) (Additional files 2, 3 and 4). Interestingly,
strain pair APC1462/APC1464, isolated from subject B
within the same week, elicits the most striking differences
(we detected 242 different genes and a lower average nu-
cleotide identity of 99.1%). It is worth mentioning that
among the genetic differences between these three strain
pairs, we found functions predicted to represent mobile
genetic elements (e.g. integrases, phage proteins as well as
a considerable amount of hypothetical proteins) (Add-
itional file 4). This suggests that horizontally trans-
ferred DNA plays an important role in causing
genome diversity in this species.
Finally, B. longum APC1461 is distinct from all other
sequenced B. longum APC/DPC strains, being the most
diverse among them in terms of gene content.
Pan-genome of B. longum species computation
In order to calculate the total gene repertoire encountered
in the newly sequenced B. longum APC/DPC genomes
a
c
b
Fig. 1 Comparative analysis of B. longum genomes. a Venn diagram displaying core gene families obtained by MCL clustering, and unique genes
of B. longum APC/DPC strains and B. longum complete genomes. b Hierarchical clustering heatmap representing the variability of B. longum in
terms of presence/absence of gene families. c Pie chart indicating the percentage of variable and core with respect to the total of gene families,
resulting from the MCL clustering algorithm. APC 1461: B. longum APC 1461; APC 1462: B. longum APC 1462; APC 1464: B. longum APC 1464;
APC 1465: B. longum APC 1465; APC 1466: B. longum APC 1466; APC 1468: B. longum APC 1468; APC 1472: B. longum APC 1472; APC 1473: B.
longum APC 1473; APC 1476: B. longum APC 1476; APC 1477: B. longum APC 1477; APC 1478: B. longum APC 1478; APC 1480: B. longum APC
1480; APC 1482: B. longum APC 1482; APC 1503: B. longum APC 1503; APC 1504: B. longum APC 1504; BLIJ: B. longum ssp. infantis ATCC15697;
BLJ: B. longum ssp. longum JDM301; BLIF: B. longum ssp. longum 157F; BBL306: B. longum ssp. longum CCUG30698; BLLJ: B. longum ssp. longum
JCM1217; B8809: B. longum ssp. longum NCIMB8809; BBMN68: B. longum ssp. longum BBMN68; BL105A: B. longum ssp. longum 105A; BL2705:
B. longum ssp. longum NCC2705; BLGT: B. longum ssp. longum GT15; BIL: B. longum ssp. longum F8; BLD: B. longum ssp. longum DJO10A;
BLNIAS: B. longum ssp. longum KACC9156; DPC 6316: B. longum DPC 6316; DPC 6317: B. longum DPC 6317; DPC 6320: B. longum DPC 6320;
DPC 6321: B. longum DPC 6321; DPC 6323: B. longum DPC 6323
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and the degree of overlap and diversity with respect to
other B. longum genomes sequenced and publicly avail-
able, a pan-genome computation was performed in two
steps employing the PGAP pipeline [26]. Firstly, we calcu-
lated the pan-genome of 37 genomes, including 17 pub-
licly available B. longum complete sequenced genomes
(Additional file 1: Table S1) and the 20 newly sequenced
B. longum APC/DPC genomes. This analysis generated a
total of 5970 gene families for this species (Fig. 2a). The
pan-genome curve was determined as the total of gene
families as a function of the number of included genomes,
and was shown to display an asymptotic trend with a
growth rate of an average of 169 families per genome in
the first 17 iterations, decreasing to an average of 55 in
the final seven additions. From this calculation, after the
inclusion of the 31st genome a minor increase in the pan
genome size is observed. Consistent with the above, the
analysis of the core-genome function shows an asymptotic
trend and stabilizes after the 22nd genome iteration reach-
ing a value of 1163 gene families at the last iteration
(Fig. 2b). The trends observed in both pan-genome and
core-genome functions indicate that the pan-genome cal-
culation for the included 37 genomes is not yet fully
closed, but approaching closure. For this reason, we con-
clude that the number of genomes analysed here provides
a comprehensive and near complete overview of the gene
repertoire of the B. longum species. Secondly, we calcu-
lated the pan-genome repertoire of just our 20 newly se-
quenced APC/DPC genomes. The total number of
identified gene families in this case was 4309 with a core-
genome size of 1295, showing an asymptotic trend con-
sistent with what was observed for the 37 B. longum
strains (Fig. 2). A comparison between the two-calculated
pan-genomes revealed that 72% of the identified gene
families are present in both, while 28% of the gene families
(1698) identified in B. longum species are absent in the 20
newly sequenced APC/DPC genomes. As expected, ana-
lysis of the 1698 gene families that did not have represen-
tatives in the newly sequenced strains showed that 60% of
these are predicted to encode hypothetical proteins,
Fig. 2 Pan-genome and core-genome of B. longum. a The pan-genome plot is represented by the accumulated number of new genes against the
number of genomes added. b The core-genome plot is represented by the accumulated number of genes attributed to the core-genomes against
the number of added genomes. The deduced mathematical function is reported. The red line represents the pan-genome and core-genome
attributed to the 20 B. longum APC/DPC strains
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transposases, putative prophage-related proteins and gen-
eric transporters. This confirms that the high genetic di-
versity observed within the B. longum APC/DPC strains is
partly attributable to what are presumed to be horizontally
transferred genes.
Phylogenetic analysis
For the purpose of analysing the phylogenetic relation-
ships between the B. longum APC/DPC strains and
other B. longum strains, a phylogenetic supertree was
created based on sequence similarities among the gene
families that constitute the core genome. The selection
of families was performed based on comparative analyses
and their presence in single copy between the complete B.
longum genomes, other B. longum draft genomes available
in the NCBI public database at the time of the study
(Additional file 1: Table S1) and Bifidobacterium breve
UCC2003 (which was selected as the outlier). The result-
ing phylogenetic tree (Fig. 3) reveals the presence of two
major branches among the analysed members of the B.
longum species. The first branch constitutes members of
the subspecies infantis taxonomic group, which contains
11 representatives (Fig. 3, Group A). The second branch is
split into two different clades (Fig. 3, Groups B & C). As
expected, we observed that most of the genomes anno-
tated as B. longum ssp. longum fall into the same subclade
(Fig. 3, Group C), in which most of the B. longum APC/
DPC genomes were positioned and uniformly spread, with
the genome of B. longum APC1461 being the only excep-
tion. As expected, each of the four pairs of strains isolated
from same babies, B. longum APC1462/APC1464, B.
longum APC1477/APC1478, B. longum APC1465/
APC1466 and B. longum APC1503/APC1482, also cluster
together. Consistent with previous findings [22], the ani-
mal–derived isolates (B. longum ssp. suis LMG21814,
DSM20211 and AGR2137) also cluster together (Fig. 3,
Group B). Interestingly, B. longum APC1461 was shown
to belong to this group. The genomes of B. longum ssp.
longum JDM301, B. longum ssp. longum CMCCP0001 and
Fig. 3 Phylogenetic analysis of B. longum. Phylogenetic supertree showing the relationship between 73 complete and incomplete B. longum
strains and B. breve UCC 2003 as an outlier. B. longum APC/DPC strains are coloured in red. Grey circles with different fillings represent isolates
from the same infant
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B. longum ssp. longum BXY01 cluster together as part of a
distinct sub-clade of Group B (Fig. 3, Group B), as had
previously been observed [22].
Glycosyl-hydrolase prediction in B. longum species
It is known that more than 13% of the genes present in
bifidobacterial genomes are predicted to be involved in
sugar metabolism, allowing bifidobacteria to metabolize
a wide range of carbohydrates [9]. In order to assess the
carbohydrate fermentation capabilities of the B. longum
APC/DPC strains, an in silico prediction of glycosyl
hydrolases (GHs) encoded in their genomes was per-
formed using the Cazy database (Fig. 4a; Additional file 1:
Table S2). This analysis revealed that the B. longum
pan-genome contains genes encoding GHs that belong
to 22 different GH families (Fig. 4b). Distributed across
various strains, GHs were found that were putatively
assigned to ferment plant-derived carbohydrates and clas-
sified as members of GH31 (α-D-xyloside xylohydrolase),
GH32 (β-fructofuranosidase), GH43 (Ara-f)(3)-Hypβ-L-
arabinobiosidase, arabinan-endo-1,5-α-L-arabinosidase,
xylan-1,4-β-xylosidase, L-arabinofuranosidase), GH51
(L-arabinofuranosidase), GH121 ((Ara-f)(3)-Hypβ-L-arab
inobiosidase), GH53 (arabinogalactan-endo-β-1,4-galactan
ase) or GH127 (L-arabinofuranosidase). Our analysis also
revealed the presence of enzymes with predicted α-galacto-
sidase (GH36, GH27), β-galactosidase (GH2, GH42), β-
glucosidase (GH1, GH3) and, though at lower abundance,
α-glucosidase (GH13), α-mannosidase (GH38), α-amylase
(GH13) and cyclomaltodextrinase (GH13) activities (Fig. 4a;
Additional file 1: Table S2). The GHs from the in silico
profile allowed us to identify certain GHs that appear to be
characteristic of our B. longum APC/DPC collection. The
most distinctive profile we found was that of strain B.
longum APC1461 (Fig. 4a). Given the phylogenomic ana-
lysis, this strain seems to belong to a separate phylogenetic
group (and may represent a separate subspecies) with gen-
omic characteristics that appear to be a mix between those
of ssp. longum and ssp. infantis members. This also is
reflected by the in silico GH profile which predicts a re-
duced number of glycolytic activities involved in hydrolysis
of plant-derived saccharidic substrates, while lacking a
complete HMO utilization cluster.
b
a
Fig. 4 The predicted glycosyl hydrolases in B. longum. a Heatmap displaying the in silico prediction of the GH family members identified in the B.
longum genomes. b Pie chart indicating the percentage of each GH family identified only in B. longum APC/DPC genomes
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In vitro bifidobacterial growth on different carbohydrate
sources
In order to assess and validate the in silico analyses, in
vitro growth assays of the B. longum APC/DPC strains
were performed involving 31 carbohydrates as sole carbon
sources (Additional file 1: Table S3; Fig. 5a; Additional
file 5). In this manner, we observed that all strains were
able to grow in the presence of lactose, which was
therefore used as a positive control in each batch cul-
ture. All strains exhibited good growth in glucose, ara-
binose, arabinogalactan and GOS. In addition, just two
strains, B. longum APC1461 and DPC6321, were cap-
able of (limited) growth with mannose as the sole carbon
source; similarly, just three strains, B. longum APC1464,
APC1477 and DPC6317, were able to achieve (limited)
growth when amylopectin was used as the sole carbon
a
b
Fig. 5 Evaluation of carbohydrate utilization by B. longum strains. a Heatmap showing the growth performance of B. longum APC/DPC strains on
different carbon sources at 12 h. b Heatmap displaying the in silico gene-trait matching exercise performed based on the association between
the presence/absence of GH families predicted and growth/no growth phenotype of the B. longum APC/DPC strains
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source. None of the 20 strains tested were able to
metabolize N-acetyl galactosamine, N-acetyl mannosa-
mine, sialic acid, pullulan, starch, inulin, xylan, mucin,
lacto-N-neotetraose (LNnT) or fucose. The fermentation
capabilities for the remainder of the tested carbohydrates
were shown to be variable among the 20 strains (Fig. 5a).
The APC1461 strain showed the most variable sugar
utilization pattern, being the only strain that was not cap-
able of growth on xylose. In contrast with other strains
tested in this study, B. longum DPC6320, DPC6321,
APC1480 and APC1503 did not exhibit any appreciable
growth on galactose as the sole carbon source. Interestingly,
B. longum APC1461 and APC1503 were not able to utilize
fructooligosaccharides (FOS) and sucrose, whereas 10 B.
longum strains were shown to only attain intermediate
growth, while the remaining eight strains displayed good
growth in the presence of these two carbohydrates (Fig. 5a).
A similar trend was found in the case of utilization of two
different sources of galactan: pectin galactan and potato
galactan. Seventeen out of the 20 strains were shown to be
able to degrade both sugars, while strains B. longum
APC1464, DPC6317 and DPC6321 did not show those
metabolic capabilities. Notably, xylo-oligosaccharides
(XOS) supported growth of half of the bifidobacterial
strains tested, whereas arabinan supported growth of 12
strains.
We tested two types of arabinoxylan (isolated from rye
or from wheat) (Additional file 1: Table S3) and growth
was observed in the presence of both carbohydrates for
14 strains, with the exception of B. longum APC1477,
which was not able to use rye arabinoxylan though it
was able to metabolize wheat arabinoxylan. Interestingly,
good growth was observed for 2′-fucosyllactose (2’-FL)
or 3’-FL as a unique carbon source for three out of 20
tested B. longum strains (Fig. 5a).
In silico gene-trait-matching
An in silico evaluation of the role of specific genes asso-
ciated with sugar metabolism found in our B. longum
genomes was performed using a gene-trait matching
(GTM) analysis based on the association between the
presence or absence of gene families, and growth/no
growth phenotype of the 20 B. longum APC/DPC
strains. The analysis was performed on those carbohy-
drates with a differential utilization profile by the B.
longum strains. The analyses allowed the identification
of five clusters of gene families that are associated with
the utilization of XOS, arabinan, arabinoxylan, galactan
and fucosyllactose (Fig. 5b; Table 2; Additional file 5).
Strain-specific growth on XOS corresponds with Cluster
A, which consists of genes predicted to encode a 1,4-
beta-xylosidase, a transporter system and a LacI-type
transcriptional regulator (Table 2). Growth on arabinan
was shown to correspond to Cluster B, which includes
genes putatively encoding three endo-1,4-beta-xylanases
and one beta-xylosidase, which is absent in all strains
that are not able to grow on arabinan. The genotype/
phenotype association also allowed us to identify a clus-
ter of genes assignable to arabinoxylan utilization in 12
out of 20 strains. This cluster (Cluster C) is predicted to
encode an exo-alpha-L-arabinofuranosidase II, three beta-
xylosidases and one alpha-arabinofuranosidase I. Despite a
partial match (<85% of phenotype/genotype concordance),
14 strains were able to metabolize arabinoxylan of which
ten contain Cluster C. Moreover, three strains which were
unable to grow on arabinoxylan were negative for this
cluster. In contrast we observed that Cluster B may also
be involved in arabinoxylan utilization, since an in silico
association between the presence/absence of both clusters
and the (in)ability to metabolize arabinoxylan was evident.
Nine out of the 20 strains were able to grow in the presence
of arabinan and arabinoxylan, and in five of these cases,
both gene clusters (B and C) were present. However, when
strains were shown to be unable to grow in the presence of
arabinan, yet capable of growth on arabinoxylan (B. longum
APC1466, DPC6323, APC1465, APC1473, APC1504) Clus-
ter C was always present. Additionally, when strains were
shown to metabolize arabinan yet did not grow on arabi-
noxylan (B. longum APC1478, APC1480), Cluster C was
absent. Nevertheless, in the three cases of no growth ob-
served on arabinan and arabinoxylan growth, we could only
match one strain with the absence of Cluster B and Cluster
C. Based on the above results, we hypothesize that both
clusters are involved in the utilization of arabinoxylan,
resulting in the observed ambiguous assignment. Further-
more, the observed strain-specific growth profile distribu-
tion on galactan matches with Cluster D, which contains a
predicted endogalactanase. Furthermore, the lack-of-
growth phenotype associated with galactan is associated
with a truncation in the endogalactanase gene (resulting in
a 107 amino acid-specifying pseudo-gene instead of the full
gene which encodes a protein of 897 amino acids) which is
believed to prevent its proper functioning. Finally, just
three strains were able to utilize 2’-FL and 3’-FL as unique
carbon sources and this specific growth profile allowed us
to identify a gene cluster (Cluster E) encoding a predicted
alpha-1,3/4-fucosidase surrounded by a LacI-like tran-
scriptional regulator, ABC transporter system, a predicted
fucose isomerase and another putative GH family 95
(Fig. 6; Table 2).
Discussion
Bifidobacterium longum is one of the most abundant
members of the human intestinal microbiota and is widely
used as a probiotic [11, 16]. B. longum ssp. longum is com-
monly present at high numbers in the gut microbiota of
humans throughout life, thus indicative of a close symbiotic
host-microbe relationship [5, 11]. Different mechanisms
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may be responsible for the highly competitive nature of this
taxon in its human host to allow stable establishment in
the complex and dynamic intestinal microbiota environ-
ment. Genomic tools and the increased number of publicly
available bifidobacterial sequences have enabled the ana-
lysis of genomic diversity and functionality in different spe-
cies [9]. In this study, we carried out an analysis of the
intra-species genomic diversity of 20 B. longum strains and
we determined their capabilities to metabolize different
carbohydrates.
We sequenced the genomes of 20 strains and performed
a comparative genomic analysis using other publicly avail-
able B. longum genome sequences. Despite the fact that
our genome sequencing, being based on Illumina short
reads, did not permit full closure of the bacterial chromo-
some, we could observe that the average G + C % content
and obtained genome size are in line with other B. longum
strains sequenced [27, 28]. In contrast to observations for
B. breve or B. bifidum pan-genomes [29, 30], the total pre-
dicted ORFs per genome was shown to exhibit a wide
range (from 1761 to 2189), indicating that B. longum
shows a higher level of genetic diversity than other bifido-
bacterial taxa, which has also been observed for the
pangenome of B. adolescentis [31]. MCL comparative
genome analysis also revealed high genomic diversity
among the B. longum APC/DPC strains. The most diverse
strain in terms of gene content was B. longum APC1461,
which harbours the highest numbers of truly unique genes
(TUGs).
The B. longum genomes analysed in this study allowed
us to describe the pan-genome of B. longum species, which
was defined as not fully closed but approaching a closed
pan-genome, being consistent with that reported by
O’Callaghan and coworkers [22]. The description of the
pan-genome of other species such as B. breve, B. bifidum,
and B. animalis ssp. lactis showed an essentially closed
trend [29, 30, 32]. In contrast, the B. adolescentis pan-
Table 2 Gene-trait matching with functions resulting from
hierarchical clustering analysis
Carbohydrate Gene cluster Functions
XYLO-
OLIGOSACCHARIDES
(XOS)
A Hypothetical protein
Putative outer membrane protein
Galactoside O-acetyltransferase
Alpha-L-arabinofuranosidase
Beta-1,4-xylosidase
ABC transporter permease
ABC transporter permease
Lactose ABC transporter
substrate-binding protein
LacI family transcriptional regulator
NADH-dependent butanol
dehydrogenase 1
ARABINAN B Endo-1,4-beta-xylanase
Endo-1,4-beta-xylanase
Beta-xylosidase
Endo-1,4-beta-xylanase
ARABINOXYLAN C ABC transporter, permease protein,
probably fructooligosaccharide
porter
ABC transporter, permease protein,
probably fructooligosaccharide
porter
ABC transporter, extracellular SBP,
probably fructooligosaccharide
porter
Exo-alpha-L-arabinofuranosidase II
Lipase
LacI family transcriptional regulator
Beta-xylosidase
Beta-xylosidase
Beta-xylosidase o endo-arabinase
Alpha-arabinofuranosidase I
GALACTAN D Solute-binding protein of ABC
transporter system for sugars
galactan metabolism
ABC transporter permease
ABC transporter permease
Beta-galactosidase galactan
metabolism
Transcriptional regulator LacI family
galactan metabolism
Glycosyl hydrolases family 53
Endogalactanase galactan
metabolism
2,5-diketo-D-gluconic acid reductase
FUCOSYLLACTOSE
(FL)
E LacI family transcriptional regulator
putative ABC transporter permease
ABC transporter permease
Table 2 Gene-trait matching with functions resulting from
hierarchical clustering analysis (Continued)
Carbohydrate Gene cluster Functions
ABC transporter substrate binding
component
Mandelate racemase/muconate
lactonizing protein
Short chain dehydrogenase
Hypothetical protein
Dihydrodipicolinate synthase
Predicted fucose isomerase
Alpha-1,3/4-fucosidase
Hypothetical protein (Glycosyl
hydrolases family 95)
Glycosyl hydrolases involved in carbohydrate utilization of each cluster
are italicized
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genome has been defined as an open pan-genome [31].
This indicates that B. longum shows higher genetic diver-
sity than other bifidobacterial taxa, with the exception of B.
adolescentis, which has also been observed to possess a
wide range of predicted ORFs per genome.
The phylogenetic tree based on sequence similarity of
core genes placed all but one (i.e. APC1461) of the B.
longum APC/DPC strains in Group C of the phylogenetic
super-tree, represented by members of the subspecies
longum taxonomic group. The resulting consensus tree
is in concordance with a previous one published by
O’Callaghan and coworkers [22]. Group B includes rep-
resentatives of the subspecies suis taxonomic group,
which comprises strains isolated from pigs and from a
calf [17, 19]. A new subspecies, B. longum ssp. sullium,
was recently proposed by differentiating the subspecies
suis taxonomic group on their ability/inability to pro-
duce urease, where the newly proposed subspecies is
urease-negative [18]. However, the inclusion of this
novel subspecies in the phylogenetic analysis was not
possible as there is currently no representative se-
quenced genome available. B. longum APC1461 was
found to carry a urease gene cluster (EC 3.5.1.5), indi-
cating that this strain resembles subspecies suis rather
than subspecies sullium. B. longum APC1461 is the first
isolate (faecal isolate of a baby) of this subspecies to be
included as a member in this clade which up until now
only contains isolates of animal origin. The rest of B.
longum APC/DPC strains were positioned clearly, yet
spread uniformly across the B. longum clade, showing a
good representation of those strains in this subspecies
taxonomic group and being consistent with the genetic
diversity observed.
The pan-genome analysis enabled an in silico prediction
of 22 GH families involved in carbohydrate metabolism.
Members of GH43 and GH13 families represented the
largest proportion of all GHs predicted in APC/DPC
genomes, accounting for 24% and 13%, respectively, and
Fig. 6 Carbohydrate utilization clusters predicted by GTM. Locus map showing gene clusters putatively involved in the utilization of various
sugars by certain B. longum strains. Glycosyl hydrolases involved in carbohydrate utilization of each cluster are also highlighted (*)
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being consistent with previous observations for the
Bifidobacterium genus [33]. These enzyme families are in-
volved in the degradation of a wide range of carbohy-
drates, including plant-derived polysaccharides, such as
amylopectin, maltodextrin, melibiose, (arabino)xylan,
amylose or trehalose [34]. Other GH families such as
GH31, GH51, GH53 or GH127, involved in plant-derived
glycan metabolism, were commonly found in APC/DPC
genomes. This enzymatic machinery is proposed to
degrade the complex plant polysaccharides into mono- and
oligosaccharides, which can then be taken up by ABC-type
transporters (for further internal hydrolysis and metabol-
ism). The B. longum APC/DPC genomes are enriched in
genes that are predicted to be involved in the metabolism
of plant-derived carbohydrates that are expected to be
present in an adult diet [22]. However, the APC/DPC ge-
nomes also encode genes involved in the metabolism of
host-derived glycans. Members of the families GH95, with
fucosidase activity; GH20, hexosaminidase activity; or
GH38, mannosidase activity, all exhibit a strain-specific
presence in APC/DPC genomes. An endo-alpha-N-acetyl-
galactosaminidase (GH101), which hydrolyses the O-glyco-
sidic bond in mucin-type O-glycan, was previously found
in B. longum JCM1217 among others [35, 36], and is also
present in all B. longum APC/DPC genomes with the only
exception being strain APC1480. However, there was a
noted absence of genes encoding sialidases or lacto-N-
biosidases, which are involved in the utilization of other
host-derived glycans, including particular HMOs [34].
The identification of genes or gene clusters which
correlate with growth or non-growth on a particular
carbohydrate was facilitated by the use of a gene-trait
matching (GTM) approach, in concordance with other
GTM analyses in different microorganisms [37]. We ob-
served a strain-specific growth profile by B. longum APC/
DPC strains on galactan, related to the presence of an
endo-beta-1,4-galactanase GH53) (GalA), which has previ-
ously been reported to be involved in galactan metabolism
by B. longum [38, 39]. Certain bifidobacterial strains/spe-
cies are able to degrade xylo-oligosaccharides (XOS) and
arabinoxylans (AX), complex molecules which contain ara-
binose and xylose substituents [40]. Both in vivo and in
vitro studies have indicated the bifidogenic effect and other
health benefits elicited by these potential prebiotics [40,
41]. The GTM approach applied here allowed us to iden-
tify a gene cluster (B) for arabinan utilization with a pre-
dicted endo-1,4-β-xylanase (GH5) as a key hydrolytic
enzyme. Moreover, a predicted 1,4-β-xylosidase (GH43) in
Cluster A is predicted to be crucial for XOS utilization,
and a similar situation has previously been identified for B.
adolescentis [42]. B. bifidum and B. longum ssp. infantis
are known to be able to metabolize many different HMOs,
and in particular the most abundant HMOs found in
breast milk, fucosylated HMOs (2′-FL and 3′-FL) [43–45].
B. longum ssp. longum strains typically do not grow on
2′-FL as sole carbon source [46, 47], though a very recent
study has described a B. longum ssp. longum strain capable
of growing on 2′-FL or 3′-FL as the unique carbon source
[48]. Interestingly, we found that three out of 20 B. longum
APC/DPC strains exhibit vigorous growth on these sugars.
This finding was supported by the prediction of a gene
cluster (E) by GTM encoding an α-fucosidase, a key en-
zyme in HMO utilization [46] and a substrate binding
component of an ABC transporter, previously found to be
essential for FL intracellular utilization and being a key
stable colonization factor of gut microbes in infants [47].
The positive strain found by Garrido and coworkers for
2′-FL and 3′-FL utilization showed a similar cluster of
genes by transcriptomics [48], verifying our observations
and the validity of our GTM approach as gene cluster
predictor.
Conclusions
In this works we studied 20 B. longum strains which had
been isolated (mostly from infants) to explore their intra-
species genomic diversity and their metabolic and genetic
variation for carbohydrate consumption. According to our
comparative genomic analysis, the results depict a snap-
shot of their substantial genetic diversity in terms of genes
and predicted GHs, as well as their ability to metabolize a
large range of sugars. The genomic/ phenotype of B.
longum ssp. longum strains is consistent with an adult diet
as exemplified by an extensive enzymatic machinery and
ability of strains to degrade plant-derived carbohydrates.
Furthermore, we found strains able to grow on particular
HMOs. Indeed, GTM analysis predicted the key gene
cluster of FL utilization, corroborating the capability of B.
longum ssp. longum species to metabolise HMOs,
although further biochemical analyses are required to con-
firm these findings. Ultimately, these observations may
provide an explanation for the persistence of B. longum
species in the gut throughout life.
Methods
Bacterial strains and growth conditions
The 20 bifidobacterial strains used in this study (Table 1)
had previously been isolated from infant faeces [49, 50]
except in two cases where the strains originate from adult
faeces, and deposited in the APC Culture Collection (APC
Microbiome Institute, Ireland). Bifidobacteria were rou-
tinely grown on de Man-Rogosa-Sharpe (MRS) medium
(Difco Laboratories, Detroit, MI) supplemented with
0.05% w/v cysteine-HCl (Sigma, St. Louis, MO) (MRSC)
and incubated at 37 °C under anaerobic conditions (10%
H2, 10% CO2, and 80% N2) in a chamber Mac 500 (Don
Whitley Scientific, West Yorkshire, UK). For solid
medium, 2% (w/v) agar (Oxoid, Basingstoke, UK) was
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added. Prior to each DNA extraction, bacteria were sub-
cultured twice and overnight cultures were used.
Genomic DNA extraction, sequencing and data assembly
DNA was isolated by the use of a DNeasy Blood & Tissue
Kit (Qiagen, Sussex, UK) following the manufacturer’s in-
structions. Briefly, the overnight culture was centrifuged,
washed with PBS (Sigma, St. Louis, MO) and incubated
for 1 h at 37 °C in an enzymatic lysis buffer with lysozyme
(50 mg/ml) (Sigma, St. Louis, MO). Then, the manufac-
turer’s protocol was followed with the extra addition of
RNAse (Sigma, St. Louis, MO). Sequencing and assem-
bly was performed by Eurofins Genetic Services Ltd.
(Ebersberg, Germany). The genomic DNA was se-
quenced on an Illumina MiSeq platform using chemis-
try v3 with paired-end sequencing. The draft genomes
were de novo assembled following a pipeline that incor-
porates Velvet software (v1.2.10) [51] and a multi-kmer
approach [52].
Contig analysis and general feature prediction
A preliminary comparative genomic analysis (methods
explained in the next section) was conducted to align
the 20 B. longum APC/DPC genomes with all complete
genomes of B. longum available in the NCBI public data-
base at the time of the study (Additional file 1: Table
S1), in order to select the most appropriate genome of
reference for ordering contigs prior to annotation. The
alignment of the 20 B. longum draft genome sequences
was performed against a number of closely related, fully
sequenced and publicly available B. longum genomes
(Additional file 1: Table S1). The B. longum JDM301, B.
longum BBMN68, B. longum NCIMB 8809, B. longum
DJ010A and B. longum GT15 genomes were thus
selected as reference genomes so as to determine pre-
sumed contig order and orientation of each draft gen-
ome. MAUVE (v2.3.1) was used to reorder contigs based
on the reference genome along with Artemis software
(v.14) for visualization and manual editing of the begin-
ning of each genome at the dnaA gene. Prediction of pu-
tative open reading frames (ORFs) was carried out using
Prodigal predictor v2.50 software (https://github.com/
hyattpd/Prodigal). Identified ORFs were then automatically
annotated on the basis of BLASTP analysis [53]. Functional
assignment was performed against the non-redundant pro-
tein database provided by the National Centre for Biotech-
nology (https://www.ncbi.nlm.nih.gov). Artemis was also
used for inspecting and editing, where necessary, the ORF
finding outputs and the associated BLASTP results. More-
over, annotations were further refined and verified using
the protein family (Pfam) (http://pfam.xfam.org) database.
Glycosyl hydrolases were predicted and annotated based on
similarity to the Carbohydrate-Active enZYmes (CAZy)
(http://www.cazy.org/) database, Enzyme Commission
number (EC) database (http://enzyme.expasy.org) using
annot8r pipeline (http://www.nematodes.org/bioinformat-
ics/annot8r) and Pfam alignments.
Comparative genomics
An all-versus-all BLASTP alignment [53] (50% identity;
e-value 1e-4 cut-off ) was performed on the extracted
protein sequences from each strain. The BLAST output
were used as an input for the clustering into protein
families sharing the same function using the Markov
Cluster Algorithm (MCL) with an inflation index of 2.5,
as previously described [29]. The obtained gene families
were classified as belonging to either the core or to the
variable genome based on their presence in either all
strains or in a subset of the investigated strains, respect-
ively. In the orthologue extraction an additional filter for
paralogues was applied by selecting only those families
that were shown to contain a single protein member for
each genome.
Pangenome analyses
In order to predict the possible dynamic changes of gen-
ome size at the genus level, the sizes of pan-genome,
core genome and unique gene, were computed. For all
the genomes used in this study, a pangenome calculation
was done using PGAP [26], as previously described [29].
The ORF content of each genome was organized in
functional gene clusters using the gene family (GF)
method implemented in the PGAP pipeline. A pan-
genome profile and a core genome profile were built
using all possible BLAST combinations for each genome
being sequentially added.
Phylogenetic analyses
The supertree computation was performed from the
alignment of a set of orthologous genes obtained
from a BLAST-based comparative approach as indi-
cated above, with the APC/DPC strains plus all B.
longum genomes available in the NCBI public data-
base at the time of writing. Each set of orthologous
proteins was aligned using MUSCLE [54] and phylo-
genetic trees were constructed using the maximum-
likelihood in PhyML [55]. The resulting consensus
tree was computed using the Consense module from
Phylip package v3.69 using the majority rule method
(http://evolution.genetics.washington.edu/phylip.html)
and phylogenetic data were submitted to TreeBASE
database (http://treebase.org/treebase-web/home.html).
Bifidobacterial growth on different carbohydrate sources
and GTM associations
For evaluation of growth on the different carbohydrates
sources, strains were cultured on modified MRS (mMRS)
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medium manually prepared to obtain the following com-
position: tryptone (10.0 g/L), yeast extract (5 g/L), beef
extract (10.0 g/L), K2HPO4 (3.0 g/L), KH2PO4 (3.0 g/L),
tri-ammonium citrate (2.0 g/L), pyruvic acid (0.2 g/L),
cysteine-HCl (0.3 g/L), Tween-80 (1 mL), MgSO4·7H2O
(0.575 g/L), MnSO4·4H2O (0.12 g/L), FeSO4·7H2O
(0.034 g/L). Prior to autoclaving, mMRS medium was
adjusted to pH 6.8.
Thirty-one carbohydrates were tested in this study
(Additional file 1: Table S3). Solutions of most of them
were prepared by dissolution at 5% (w/v) in distilled
water and sterilized by filtration (0.45 μm). They were
then added to mMRS medium at final concentration of
0.5% (v/v). Since certain carbohydrates do not easily dis-
solve in water (pullulan, starch, amylopectin, inulin, ara-
binoxylan (wheat and rye), pectin galactan, mucin,
galactan potato, pectin apple, arabinan, arabinogalactan,
xylan and amylopectin), they were added directly to
mMRS medium at a final concentration of 0.5% (w/v)
and autoclaved at 121 °C for 15 min.
For growth assays, Bifidobacterium strains were cul-
tured at 37 °C under anaerobic conditions in 10 ml of
MRSC. Afterwards they were sub-cultured twice, first at
2% (v/v) into 10 mL of fresh medium during 8 h, and
then at 1% (v/v) into 10 mL of MRSC fresh medium
overnight. The next day, strains were inoculated at 1%
(v/v) into 10 mL of mMRS medium, previously supple-
mented with the soluble carbohydrates at a final concen-
tration of 0.5% (v/v) or directly to mMRS with
non-soluble carbohydrate autoclaved. Prior to inocula-
tion, both media were supplemented with cysteine-HCl
at a final concentration of 0.05%.
Growth of the bacterial strains was evaluated by optical
density (OD600 nm) using UV-1280 spectrophotometer
(Schimadzu Corporation, Kyoto, Japan). Measurements
were taken manually over a 24-h period at different time
points: 0, 6, 9, 12 and 24 h. mMRS supplemented with
0.05% w/v cysteine-HCl and without the addition of a
carbohydrate source served as a negative control. Based
on the OD600 nm values at 12 h, bacterial growth was cate-
gorized as good growth (+) with an OD600 nm higher than
0.5 and moderate growth (+−) with an OD600 nm between
0.4 and 0.5. A cut-off value of 0.4 OD600 nm was used to
discriminate strains which were not able to grow in the
given carbohydrates.
Following completion of the fermentation assessment
of B. longum strains, an in silico genotype/phenotype
gene-trait matching (GTM) exercise was performed, cor-
relating the presence/absence of genes obtained from
comparative analysis with an observed phenotype.
The analysis was performed on a subset of gene families
obtained after exclusion of the ones present in all the
strains (core-genome). A further filter was included which
excluded from the analysis that fraction of genes not
involved in carbon source utilization (e.g. transposases, R/
M systems, CRISPR systems and prophages).
After obtaining the final number of families, a further
reduction of the dataset in clusters of unique combin-
ation of occurrence was performed which allowed us to
obtain the “genotype” binary matrix (values 0 for
absence and 1 for presence of a gene family). This ob-
tained matrix contained 372 clusters on the rows and 20
strains on the columns. A second binary matrix was also
similarly generated containing the fermentation profile
and constituting the “phenotype”. In this case, a value of
0 was assigned for OD600 < 0.3 and value of 1 for
OD600 > 0.4 (taken at 12 h of growth curve). The
“phenotype” binary matrix contained 16 carbohydrates
on the rows and 20 strains on the columns, organized in
the same order as in the genotype.
Following alignment of these two matrices, the matching
percentage between each row of the two matrices and the
result was represented as a heatmap. The positive matches
obtained from the analysis (> 95% of match between
“genotype” and “phenotype”) as well as the relative genomic
surrounding regions were further inspected and compared
with additional information retrieved from alternative avail-
able databases such as EC (Enzyme Classification) database
[56] and PFAM (http://pfam.sanger.ac.uk) alignments, in
order to further support the obtained results [29].
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